Wednesday 6 November
10am – 10.20am
Implementing the Lord O'Shaughnessy’s recommendations for UK commercial clinical trials: 18 months on
Presentation
10.40am – 11am
Reforming the UK’s clinical trials regulatory framework and new approach across the clinical trial lifecycle
Presentation
11.45am – 12pm
Perspective from a clinician on conducting clinical trials in the UK
Presentation
1.30pm – 1.45pm
The International Recognition Procedure for medicines: 10 months on
Presentation
1.45pm – 2pm
Innovative Licensing and Access Pathway Refresh: What’s on offer to developers of innovative products
Presentation
2pm – 2.15pm
Perspective from NICE on collaborative working and improving patient access to innovative medicines
Presentation
2.15pm – 2.30pm
Perspective from NHS England on working together with MHRA and NICE in the access pathway
Presentation
3.30pm – 3.45pm
MHRA data strategy: Overview and collaboration at UK and global level
Presentation
3.45pm – 4pm
Real World Date (RWD) Quality considerations for regulatory purposes
Presentation
4pm – 4.15pm
The use of RWD across the product lifecycle during global drug development
Presentation
